A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
A multicenter study to evaluate the effectiveness and safety of multiple dosage regimens of an investigational drug for the treatment of constipation due to prescription pain medication in subjects with cancer pain. The study will require five visits over a five-week period.
Inclusion criteria:
Exclusion criteria:
Capital Federal, Buenos Aires C1405CUB, Argentina
Pokfulam, Hong Kong
Zalaegerszeg-Pozva, 8900, Hungary
St'Petersburg, 195247, Russia
Groenkloof, Pretoria, South Africa
Houghton, Johannesburg, 2000, South Africa
Kenilworth, Cape Town, 7745, South Africa
Sabadell / Barcelona, Spain
Serra / Valencia, Spain
Surrey, SM2 5PT, United Kingdom